BMC Cancer
Prognostic relevance of ZEB1, ZEB2 and CD105 expression in breast carcinomas
Abstract Background The epithelial–mesenchymal transition (EMT) transcription factors ZEB1 and ZEB2 play critical roles in cancer progression and metastasis. CD105 (endoglin), a marker of neovascularization, has also been implicated in tumor aggressiveness. However, their combined prognostic and clinicopathological relevance in breast carcinoma remains underexplored. Methods We evaluated ZEB1, ZEB2, and CD105 expression in the epithelial compartment of the tumor and tumor stroma via immunohistochemistry in 258 inva …